Publications
350 publications
Sort by: Date / Relevance
International strategic agenda 2022-2023 National Health Care Institute
The international strategic agenda 2022-2023 describes the international activities of the National Health Care Institute ...
Package advice tisagenlecleucel (Kymriah®) for the treatment of r/r DLBCL
The National Health Care Institute has completed its reassessment whether tisagenlecleucel (Kymriah®) can be included in the ...
Package advice acalabrutinib (Calquence®) for the treatment of chronic lymphatic leukaemia
The National Health Care Institute has completed its assessment whether acalabrutinib (Calquence®) can be included in the insured ...
GVS advice on volanesorsen (Waylivra)
The National Health Care Institute advises the Minister to include volanesorsen on List 1B of the GVS. Volanesorsen (Waylivra®) ...
Package advice ravulizumab (Ultomiris®) for the treatment of PNH and aHUS
The National Health Care Institute has completed its assessment whether ravulizumab (Ultomiris®) can be included in the insured ...
GVS advice tirbanibulin (Klisyri®) for the treatment of adults with actinic keratosis
The National Health Care Institute recommends the Minister to include tirbanibulin on List 1A in cluster 0D06BBADC V of the GVS. ...
Package advice venetoclax (Venclyxto®)
The National Health Care Institute has completed its assessment whether venetoclax (Venclyxto®) can be included in the insured ...
GVS assessment ponesimod (Ponvory®) for the treatment of relapsing forms of multiple sclerosis (RMS)
National Health Care Institute has completed its assessment whether ponesimod (Ponvory®) can be included in the ...
Package advice cemiplimab (Libtayo®) for the treatment of non-small cell lung carcinoma (NSCLC)
Zorginstituut Nederland has completed its assessment whether cemiplimab (Libtayo®) as primary care treatment for stage IIIBC-IV ...
GVS assessment empagliflozin (Jardiance®) for the treatment of adults with chronic heart failure
The National Health Care Institute recommends the Minister for Medical Care to extend the reimbursement condition of ...